Treatment of severe psoriasis with ixekizumab in a liver transplant recipient with concomitant hepatitis B virus infection

Research output: Contribution to journalArticlepeer-review

Abstract

Treatment of severe psoriasis (PsO) in organ transplant (OT) patients is difficult. In fact, systemic drugs used for PsO therapy can be detrimental to transplanted organs and/or can increase the risk of serious infections in subjects already taking antireject medicines. Current guidelines fail to give indications on how to manage PsO OT subjects. Moreover, only a few cases of patients with the above-cited characteristics treated with systemic therapies have been published so far. Here, we report our experience concerning a liver transplant patient successfully treated with ixekizumab for his psoriasis throughout 1 year.

Original languageEnglish
Article numbere12909
JournalDermatologic Therapy
Volume32
Issue number3
DOIs
Publication statusPublished - May 1 2019

Keywords

  • ixekizumab
  • organ transplant
  • psoriasis

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'Treatment of severe psoriasis with ixekizumab in a liver transplant recipient with concomitant hepatitis B virus infection'. Together they form a unique fingerprint.

Cite this